Noelia Rycerz brings more than 19 years of global drug development experience to her role as Vice President of Clinical Operations at AVEO Oncology, an LG Chem company. Ms. Rycerz has held roles of increasing seniority in Clinical Operations and Program Management at Amgen Inc. (“Amgen”), Pfizer Inc. (“Pfizer”), and Odonate Therapeutics, Inc. She has led and executed phase 1–3 clinical trials in varying therapeutic areas, including oncology, rheumatology, and cardiovascular disease. During Ms. Rycerz time at Amgen as a Program Manager, she supported CMC, Regulatory and Safety Affairs to ensure delivery of marketing applications leading to approval of Corlanor^®. While at Pfizer, Ms. Rycerz was accountable for oversight of pivotal clinical trials and support of regulatory inspections leading to marketing application approvals for Xeljanz^®, Besponsa^®, and Daurismo^®.

Ms. Rycerz received her Bachelor of Science from Boston University.